Inactive Instrument

Press Releases Viropro Inc. Other OTC

Equities

VPRO

US9282422057

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Viropro : May 2, 2016 -- Letter of Intent to Acquire NovaRx Expires; Viropro Appoints New Slate of Officers	16-05-02	PU
Viropro : Letter of Intent to Acquire NovaRx Expires; Viropro Appoints New Slate of Officers	16-05-02	PR
Viropro : December 8, 2015 -- Dr. Ivor Royston, Oncologist, Entrepreneur, Investor and a Founder of San Diego Biotech, Joins Viropro Board	15-12-08	PU
Viropro : October 22, 2015 -- Viropro Announces Signing of Letter of Intent to Acquire NovaRx	15-10-23	PU
Viropro : October 9, 2015 -- Viropro Announces Appointment of Ciro E. Adams, CPA, LLC, as New Audit Firm, Secures Additional $200,000 in Convertible Debt	15-10-09	PU
Viropro : September 11, 2015 -- Viropro Files Complaint Against PricewaterhouseCoopers Alleging Fraud and Breach of Fiduciary Duty	15-09-11	PU
Viropro : December 23, 2014 -- Viropro Opposes Sale of Assets by Receiver and Manager	14-12-23	PU
Viropro : FOR IMMEDIATE RELEASE – Court Recognizes Majority of Viropro Shareholders’ Election of New Board of Directors	14-06-04	PU
Viropro : Spring Hill Update	14-04-11	PU
Viropro, Inc. : Alpha Biologics SDN Nominated for Best Practices Award from Frost & Sullivan	13-05-28	PU
Viropro, Inc. : FOR IMMEDIATE RELEASE Viropro and Oncobiologics Sign Emerging Markets Biosimilars Deal	13-05-28	PU
Viropro, Inc. : Viropro is Presenting at the Biotech Showcase™ 2013	13-05-28	PU
Viropro, Inc. : Viropro and CoreRx Enter into a Reciprocal Referral Agreement	12-12-14	PU
Viropro, Inc. : Biotech Showcase 2013	12-12-14	PU
Viropro, Inc. : to Unlock Value from its Biosimilars Portfolio	12-05-16	PU
Viropro, Inc. : Appoints Cynthia Ekberg Tsai as Chairperson of	11-10-19	PU
Viropro, Inc. : Appoints Michelle Peake to Chief Executive Officer of Alpha Biologics Sdn Bhd	11-10-02	PU
VIROPRO : changes name	11-06-06	PU
VIROPRO : Biologics Process Development Inc. to Double the Size of its Bioprocess Laboratory	11-05-24	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019

Replicate our performance

fermer